jan 1, 2014 - Pembrolizumab
Description:
FDA approves pembrolizumab for the treatment of advanced melanoma. This monoclonal antibody blocks the activity of a protein called PD1 on immune cells, which increases the strength of immune responses against cancer.
Added to timeline:
Date: